Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
The impact of bedaquiline and delamanid containing regimens on liver function in patients multi-infected with pulmonary DR-TB, HIV and viral hepatitis Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
Clinical-evolutive aspects of pulmonary tuberculosis at patients with chronic hepatitis Source: Annual Congress 2007 - Tuberculosis Year: 2007
Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection Source: ISSN=ISSN 1810-6838, ISBN=, page=190 Year: 2006
Prevention of drug-induced liver injury in patients with pulmonary tuberculosis and chronic hepatitis C Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
The risk of hepatotoxicity of anti-tuberculosis drugs in patients from regions with high prevalence of hepatitis B Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Concomitant intestinal parasitic infections in patients with respiratory disease Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Viral agents in children with lower respiratory tract infection Source: Eur Respir J 2006; 28: Suppl. 50, 487s Year: 2006
Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229 Year: 2004
Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007
Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013